JPMorgan raised its price target on Colgate-Palmolive to $96 from $95 while keeping an Overweight rating. The $1 increase is a minor positive signal, but the article does not cite any change in fundamentals, earnings, or guidance. This is routine analyst commentary and is unlikely to materially move the stock on its own.
JPMorgan raised its price target on Colgate-Palmolive to $96 from $95 while keeping an Overweight rating. The $1 increase is a minor positive signal, but the article does not cite any change in fundamentals, earnings, or guidance. This is routine analyst commentary and is unlikely to materially move the stock on its own.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.15
Ticker Sentiment